Literature DB >> 19768563

Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study.

Akane Ui1, Shinichi Kuriyama, Masako Kakizaki, Toshimasa Sone, Naoki Nakaya, Kaori Ohmori-Matsuda, Atsushi Hozawa, Yoshikazu Nishino, Ichiro Tsuji.   

Abstract

OBJECTIVES: To investigate the association between green tea consumption and liver cancer incidence.
METHODS: We prospectively followed 41,761 Japanese adults aged 40-79 years, without a history of cancer at the baseline or any missing data for green tea consumption frequency. Cox proportional hazards models were used to calculate hazard ratios (HR) with 95% confidence intervals (CI), adjusted for age, alcohol drinking, smoking, the consumption of coffee, vegetables, dairy products, fruit, fish, and soybean.
RESULTS: Over 9 years of follow-up, among 325,947 accrued person-years, the total incidence of liver cancer was 247 cases. We found that green tea consumption was inversely associated with the incidence of liver cancer. In men, the multivariate-adjusted HRs (95% CIs) for liver cancer incidence with different green tea consumption categories were 1.00 (reference) for <1 cup/day, 0.83 (0.53-1.30) for 1-2 cups/day, 1.11 (0.73-1.68) for 3-4 cups/day, and 0.63 (0.41-0.98) for >/=5 cups/day (p for trend = 0.11). The corresponding data among women were 1.00 (reference), 0.68 (0.35-1.31), 0.79 (0.44-1.44), 0.50 (0.27-0.90) (p for trend = 0.04).
CONCLUSIONS: Green tea consumption is associated with a reduced risk of liver cancer incidence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19768563     DOI: 10.1007/s10552-009-9388-x

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  19 in total

Review 1.  The effect of green tea intake on risk of liver disease: a meta analysis.

Authors:  Xueru Yin; Jiqiao Yang; Tony Li; Liyan Song; Tinglu Han; Mei Yang; Huihua Liao; Jianjun He; Xiaozhu Zhong
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  A Review on Dietary and Non-Dietary Risk Factors Associated with Gastrointestinal Cancer.

Authors:  Lohith Mysuru Shivanna; Asna Urooj
Journal:  J Gastrointest Cancer       Date:  2016-09

3.  Cancer prevention by green tea: evidence from epidemiologic studies.

Authors:  Jian-Min Yuan
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

Review 4.  Tea and cancer prevention: epidemiological studies.

Authors:  Jian-Min Yuan; Canlan Sun; Lesley M Butler
Journal:  Pharmacol Res       Date:  2011-03-23       Impact factor: 7.658

5.  Association between tea and coffee consumption and risk of laryngeal cancer: a meta-analysis.

Authors:  Zhiguo Ouyang; Zhaoyan Wang; Jian Jin
Journal:  Int J Clin Exp Med       Date:  2014-12-15

6.  An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice.

Authors:  Ying Fu; Shana Silverstein; Justine N McCutcheon; Marcin Dyba; Raghu G Nath; Monika Aggarwal; Heidi Coia; Angela Bai; Jishen Pan; Jiji Jiang; Bhaskar Kallakury; Hongkun Wang; Yu-Wen Zhang; Giuseppe Giaccone; Aiwu Ruth He; Fung-Lung Chung
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

7.  Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population.

Authors:  Yanli Li; Shen-Chih Chang; Binh Y Goldstein; William L Scheider; Lin Cai; Nai-Chieh Y You; Heather P Tarleton; Baoguo Ding; Jinkou Zhao; Ming Wu; Qingwu Jiang; Shunzhang Yu; Jianyu Rao; Qing-Yi Lu; Zuo-Feng Zhang; Lina Mu
Journal:  Cancer Epidemiol       Date:  2011-02-10       Impact factor: 2.984

8.  Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study.

Authors:  Shane Johnson; Woon-Puay Koh; Renwei Wang; Sugantha Govindarajan; Mimi C Yu; Jian-Min Yuan
Journal:  Cancer Causes Control       Date:  2011-01-22       Impact factor: 2.506

9.  In vivo detection of a novel endogenous etheno-DNA adduct derived from arachidonic acid and the effects of antioxidants on its formation.

Authors:  Ying Fu; Raghu G Nath; Marcin Dyba; Idalia M Cruz; Sharanya R Pondicherry; Aileen Fernandez; Casey L Schultz; Peiying Yang; Jishen Pan; Dhimant Desai; Jacek Krzeminski; Shantu Amin; Plamen P Christov; Yukihiko Hara; Fung-Lung Chung
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

10.  The catechol-O-methyltransferase inhibitor, tolcapone, increases the bioavailability of unmethylated (-)-epigallocatechin-3-gallate in mice.

Authors:  Sarah C Forester; Joshua D Lambert
Journal:  J Funct Foods       Date:  2015-08-01       Impact factor: 4.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.